Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement
2005
300 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
16.83
Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement | Researchclopedia
·
Bayer (Germany)
Peter Kälebo
·
Östersunds Hospital